BioNTech SE technical analysis
Technical analysis of BioNTech SE (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is BioNTech SE
BioNTech SE is a German pharmaceutical company engaged in the development and commercialization of immunotherapies, with a focus on mRNA vaccines and oncology drugs. The company's pipeline includes the BNT162 vaccine for SARS-CoV-2 and multiple drug candidates in clinical trials for the treatment of solid tumors and infectious diseases.
Description generated automatically from public sources; it may be inaccurate or out of date.
BioNTech SE: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
102.34 $
+1.39%
50 sessions
96.51 $
+7.51%
200 sessions
97.66 $
+6.24%
Session levels
s2
100.53
Support
s1
101.70
Support
pivot
103.43
Pivot
r1
104.60
Resistance
r2
106.33
Resistance
How to read it
In the September 4, 2026 session BioNTech SE closed higher at 103.76 $, +0.86% versus the previous session.
The price sits above every moving average observed: +1.39% against the 21-session average, +7.51% against the 50 and +6.24% against the 200.
The 14-period RSI reads 54.0, in neutral territory.
MACD stands at 2.652 against a signal line at 3.470: the histogram is negative (−0.818).
ADX reads 25.5, indicating a marked directionality.
Levels computed on the latest session place supports at 101.70 and 100.53 $ and resistances at 104.60 and 106.33 $, around a pivot of 103.43.
The average daily range (ATR) is 4.200 $, or 4.05% of price.
Turnover was 575.9K shares, 34% of the 20-session average.
Over the last twelve months the price ranged between 84.78 and 120.33 $, and today stands −13.77% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the BNTX analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about BioNTech SE
How is BioNTech SE analysed technically?
Technical analysis of BioNTech SE is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for BioNTech SE?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to BioNTech SE?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to BioNTech SE it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.